A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

First Successful Total Knee Replacement Performed in the U.S. Using Pixee Medical’s Knee+ Augmented-Reality Platform

Pixee Medical’s Knee+ AR computer-assisted orthopedic solution deployed for the first-ever use in the United States with the MicroPort Evolution® Medial-Pivot Knee system

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces the successful completion of the first surgery in the U.S. utilizing Pixee Medical, an FDA-cleared augmented reality surgical application for assistance in total knee arthroplasties.

The surgery was performed by Dr. Antonia F. Chen, M.D., M.B.A., an orthopedic surgeon at Brigham and Women’s Hospital in Boston, MA, using MicroPort Orthopedics Evolution® Medial-Pivot Knee system, designed to deliver a high degree of stability and motion, leading to increased patient satisfaction and survivorship. In conjunction with Pixee’s Knee+ platform, the surgeon is able to achieve excellent precision and control, which may result in more efficiency in the operating room and a quicker return to full function for the patient.
Pixee Medical’s Knee+ is a patented platform designed to assist orthopedic surgeons to perform surgeries better and faster by providing real-time positioning of instruments, right in their field of view via smartglasses. Knee+ is intuitive and requires minimal training since it does not change the overall technique for 90 percent of surgeons who use a conventional technique but have never utilized navigation or robots.
“Our mission at MicroPort is to help the patient achieve full function, faster – and this ability to enhance precision and results during surgery will do just that,” said Benny Hagag, President of MicroPort Orthopedics. “The Pixee platform will be transformative in the continued efficiency and precision of our device systems.”
“The first use of Knee+ in Boston is an important step forward as the U.S. represents 50 percent of the worldwide market,” said Sébastien Henry, Founder and CEO of Pixee Medical. “Pixee’s platform is designed to become the cornerstone of data acquisition and exchange during surgery. We look forward to expanding the use of this technology within the US market.”
MicroPort Orthopedics offers various products and techniques to help patients receiving total hip and knee replacements achieve Full Function, Faster. For more information on MicroPort Orthopedics, visit www.microportortho.com.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy